CAMBRIDGE, England, March 18, 2024 /PRNewswire/ — Abcam announced the appointment of Markus Lusser as President.
Markus Lusser
Markus joined Abcam at a pivotal moment as the company transitions into the Danaher Life Sciences portfolio. With extensive experience in the life sciences and medical device industries, Markus aims to enhance Abcam’s innovative solutions for customers.
He previously served in leadership roles at Danaher and Siemens Healthineers, driving growth and innovation. Markus emphasizes building customer-centric cultures and fostering cross-functional teamwork.
His mission as Abcam’s President is to prioritize customer needs, collaboration, and innovation. Markus replaces Alan Hirzel as CEO. Abcam, headquartered in Cambridge, UK, operates globally and serves researchers worldwide with its biological reagents and solutions.
Table of Contents
Leave a Reply
You must be logged in to post a comment.